Who owns ADICET BIO INC?
- CUSIP Number: 007002108
Tip: Access positions for across all investors
Analyze quarterly positions in Adicet Bio with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Adicet Bio stock
Who bought or sold ADICET BIO INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 7.5M | $6.1M | 0% | Sep 2025 |
|
| Bridgeway Capital Management | 902k | $731k | 0% | Sep 2025 |
|
| Two Sigma Investments | 855k | $692k | 67% | Sep 2025 |
|
| Two Sigma Advisers | 781k | $633k | 38% | Sep 2025 |
|
| Rbf Capital | 617k | $500k | 0% | Sep 2025 |
|
| Citadel Advisors | 584k | $473k | 20% | Sep 2025 |
|
| Millennium Management | 566k | $459k | -4% | Sep 2025 |
|
| Royal Bank of Canada | 80k | $65k | 90934% | Sep 2025 |
|
| Regeneron Pharmaceuticals | 61k | $510k | -94% | Dec 2025 |
|
| FMR | 776.00 | $629.025600 | -100% | Sep 2025 |
|
| Jpmorgan Chase & Co | 771.00 | $624.972600 | 100% | Sep 2025 |
|
Who sold out of Adicet Bio?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| OrbiMed Advisors | Sep 2025 | 11M | $9.3M |
| Tang Capital Management | Sep 2025 | 8.2M | $6.7M |
| Goldman Sachs Group | Sep 2025 | 3.8M | $3.0M |
| Vanguard Group | Sep 2025 | 3.3M | $2.7M |
| Carlyle | Sep 2025 | 2.9M | $2.4M |
| Acadian Asset Management | Sep 2025 | 2.3M | $1.8M |
| Renaissance Technologies | Sep 2025 | 1.8M | $1.5M |
| Geode Capital Management | Sep 2025 | 706k | $573k |
| Alyeska Investment Group | Sep 2025 | 656k | $531k |
| BlackRock | Sep 2025 | 585k | $474k |
| Schonfeld Strategic Advisors | Sep 2025 | 479k | $388k |
| Johnson & Johnson | Sep 2025 | 365k | $295k |
| Wealthedge Investment Advisors | Sep 2025 | 300k | $243k |
| State Street Corporation | Sep 2025 | 244k | $198k |
| Jane Street | Sep 2025 | 186k | $151k |
| Northern Trust | Sep 2025 | 140k | $114k |
| Vontobel Holding | Sep 2025 | 80k | $65k |
| Virtu Financial | Sep 2025 | 80k | $65k |
| Rangeley Capital | Sep 2025 | 75k | $61k |
| XTX Topco | Sep 2025 | 58k | $47k |
| Dimensional Fund Advisors | Sep 2025 | 53k | $43k |
| Marshall Wace | Sep 2025 | 52k | $42k |
| Squarepoint Ops | Sep 2025 | 46k | $38k |
| Susquehanna International | Sep 2025 | 40k | $33k |
| Abacus Planning Group | Sep 2025 | 37k | $30k |
| Two Sigma Securities | Sep 2025 | 25k | $21k |
| D. E. Shaw & Co | Jun 2025 | 22k | $14k |
| UBS Group | Sep 2025 | 21k | $17k |
| Qube Research & Technologies | Sep 2025 | 20k | $16k |
| Hrt Financial | Sep 2025 | 19k | $15k |
| Mariner Wealth Advisors | Sep 2025 | 15k | $12k |
| Raymond James Financial | Sep 2025 | 13k | $11k |
| Tower Research Capital | Sep 2025 | 5.0k | $4.0k |
| Hollencrest Securities | Sep 2025 | 2.0k | $1.6k |
| Toth Financial Advisory Corporation | Sep 2025 | 1.6k | $1.3k |
| Bnp Paribas Arbitrage, Snc | Sep 2025 | 896.00 | $726.028800 |
| SBI Securities | Sep 2025 | 827.00 | $670.035400 |